Regulation of CCK mRNA expression in the rat brain by stress and treatment with sertraline, a selective serotonin re-uptake inhibitor

Brain Research

Volumn 824, Issue 2, 1999, Pages 304-307

  Giardino, Luciana ^a,b   Bettelli, Carla ^b   Pozza, Monica ^b   Calzà, Laura ^b,c  

^a UNIVERSITY OF MILAN   (Italy)

^b HESPERIA HOSPITAL   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

CCK mRNA; In situ hybridization; Rat; Restraint stress; Sertraline

Indexed keywords

CHOLECYSTOKININ; MESSENGER RNA; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; METABOLIC REGULATION; MICRODENSITOMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS; THALAMUS;

ANIMALS; BRAIN; CEREBRAL CORTEX; CHOLECYSTOKININ; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; RESTRAINT, PHYSICAL; RNA, MESSENGER; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; STRESS; THALAMUS;

EID: 0033541506     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01242-1     Document Type: Article

References (21)

1. R.E. Adamec, T. Shallow, J. Budgell, Blockade of CCK(B) but not CCK(A) receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: implications for anxiety associated with post-traumatic stress disorder, Behav. Neurosci. 111 (1997) 435-449.
2. J. Bradwejn, C. de Montigny, Benzodiazepine antagonize cholecystokinin-induced activation of rat hippocampal neurons, Nature 312 (1984) 363-364.
3. D.S. Charney, A. Deutch, A functional neuroanatomy of anxiety and fear: implications for the pathophysiology and treatment of anxiety disorders, Crit. Rev. Neurobiol. 10 (1996) 419-446.
4. E.A. Del Bel, F.S. Guimaraes, Social isolation increases cholecystokinin mRNA in the central nervous system of rats, NeuroReport 8 (1997) 3597-3600.
5. G.B. Glavin, W.P. Pare, T. Sandbak, H.K. Bakke, R. Murison, Restraint stress in biomedical research: an update, Neurosci. Biobehav. Rev. 18 (1994) 223-249.
6. L. Giardino, M. Zanni, A. Velardo, G. Amato, L. Calzà, Effect of sertraline treatment on benzodiazepine receptors in the rat brain, J. Neural. Trans. 94 (1993) 31-41.
7. L. Giardino, M. Zanni, C. Bettelli, M.A. Savina, L. Calzà, Regulation of glutamic acid decarboxylase mRNA expression in rat brain after sertraline treatment, Eur. J. Pharmacol. 312 (1996) 183-187.
8. L. Giardino, M. Zanni, M. Pozza, C. Bettelli, V. Covelli, Dopamine receptors in the striatum of rats exposed to repeated restrain stress and alprazolam treatment, Eur. J. Pharmacol. 344 (1998) 143-147.
9. J.M. Gorman, The use of newer antidepressants for panic disorder, J. Clin. Psych. 58 (1997) 54-58, supp. 14.
10. J. Harro, J. Bradwejn, CCK in animal and human research on anxiety, Trends Pharmacol. Sci. 14 (1993) 244-249.
11. J. Harro, C. Lofberg, J.F. Rehfeld, L. Oreland, Cholecystokinin peptides and receptors in the rat brain during stress, Naunyn Schmiedebergs Arch. Pharmacol. 354 (1996) 59-66.
12. T. Hökfelt, J.F. Rehfeld, L. Skirboll, B. Ivemark, M. Goldstein, K. Marley, Evidence for coexistence of dopamine and CCK in mesolimbic neurones, Nature 285 (1980) 476-478.
13. K.K. Miller, A. Hoffer, K.R. Svoboda, C.R. Lupica, Cholecystokinin increases GABA release by inhibiting a resting K+ conductance in hippocampal interneurons, J. Neurosci. 17 (1997) 4994-5003.
14. R. Mongeau, P. Blier, C. de Montigny, The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments, Brain Res. Rev. 23 (1997) 145-195.
15. D.V. Sheehan, K. Harnett-Sheehan, The role of SSRIs in panic disorder, J. Clin. Psych. 57 (1996) 51-58, suppl. 10.
16. J. Shlik, A. Aluoja, V. Vasar, E. Vasar, T. Podar, J. Bradwejn, Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder, J. Psychiatry Neurosci. 22 (1997) 332-340.
17. L.W. Swanson, C. Kohler, A. Bjorklund, The limbic region: I. The septohippocampal system, in: A. Björklund, T. Hökfelt, L.W. Swanson (Eds.), Handbook of Chemical Neuroanatomy, Vol. 5: Integrated Systems of the CNS, Part I, Elsevier, Amsterdam, 1987, pp. 125-278.
18. H.J. van Megen, J.A. den Boer, H.G. Westenberg, On the significance of cholecystokinin receptors in panic disorder, Prog. Neuropsychopharmacol, Biol. Psychiatry 18 (1994) 1235-1246.
19. H.J. van Megen, H.G. Westenberg, J.A. den Boer, R.S. Kahn, Cholecystokinin in anxiety, Eur. Neuropsychopharmacol. 6 (1996) 263-280.
20. Z. Wang, J. Valdes, R. Noyes, T. Zoega, R.R. Crowe, Possible association of a cholecystokinin promoter polymorphism (CCK- 36CT) with panic disorder, Am. J. Med. Genet. 81 (1998) 228-234.
21. U. Zippel, P. Henklein, Effects of two newly synthesized cholecystokinin tetrapeptides on the activity of single hippocampal and thalamic neurons, Neuropeptides 29 (1995) 83-87.